z-logo
open-access-imgOpen Access
Genomic epidemiology and evolutionary dynamics of respiratory syncytial virus group B in Kilifi, Kenya, 2015–17
Author(s) -
Everlyn Kamau,
James R. Otieno,
Nickson Murunga,
John W. Oketch,
Joyce M. Ngoi,
Zaydah R. de Laurent,
Anthony Mwema,
Joyce U. Nyiro,
Charles N. Agoti,
D. James Nokes
Publication year - 2020
Publication title -
virus evolution
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.231
H-Index - 23
ISSN - 2057-1577
DOI - 10.1093/ve/veaa050
Subject(s) - viral phylodynamics , nonsynonymous substitution , evolutionary dynamics , biology , genetic diversity , virus , evolutionary biology , genome , virology , epidemiology , molecular epidemiology , genetics , phylogenetics , genotype , population , gene , environmental health , medicine
Respiratory syncytial virus (RSV) circulates worldwide, occurring seasonally in communities, and is a leading cause of acute respiratory illness in young children. There is paucity of genomic data from purposively sampled populations by which to investigate evolutionary dynamics and transmission patterns of RSV. Here we present an analysis of 295 RSV group B (RSVB) genomes from Kilifi, coastal Kenya, sampled from individuals seeking outpatient care in nine health facilities across a defined geographical area (∼890 km 2 ), over two RSV epidemics between 2015 and 2017. RSVB diversity was characterized by multiple virus introductions into the area and co-circulation of distinct genetic clusters, which transmitted and diversified locally with varying frequency. Increase in relative genetic diversity paralleled seasonal virus incidence. Importantly, we identified a cluster of viruses that emerged in the 2016/17 epidemic, carrying distinct amino-acid signatures including a novel nonsynonymous change (K68Q) in antigenic site ∅ in the Fusion protein. RSVB diversity was additionally marked by signature nonsynonymous substitutions that were unique to particular genomic clusters, some under diversifying selection. Our findings provide insights into recent evolutionary and epidemiological behaviors of RSVB, and highlight possible emergence of a novel antigenic variant, which has implications on current prophylactic strategies in development.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom